Literature DB >> 27056582

Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003-2014).

David M Arana1, Margarita Rubio2, Juan-Ignacio Alós3.   

Abstract

INTRODUCTION: The aim of this study was to identify multi-drug resistance (MDR) in the main enterobacteriaceae implicated in urinary tract infections (Escherichia coli and Klebsiella pneumoniae) from both, community and hospitalized patients and to analyze the evolution over a 12-year period.
METHODS: Microb Dynamic software was used to analyze the microbiology laboratory database and a chi square test was applied to compare differences in group proportions and to determine the linear trend over 12 years in three different periods: 2003-2006, 2007-2010, 2011-2014. We chose amoxicillin, gentamicin, ciprofloxacin and trimethoprim-sulphamethoxazole as MDR markers.
RESULTS: A total of 39,980 positive urine samples were analyzed, 34,564 (3786 from hospitalized patients and 30,778 from non-hospitalized patients) E. coli isolates, and 5,422 (774 from hospitalized patients and 4,648 from non-hospitalized patients) K. pneumoniae isolates. The prevalence of UTI due to MDR E. coli and MDR K. pneumoniae significantly increased in the period studied, both in hospitalized and outpatients. A higher percentage of MDR E. coli (5.89% in 2007-2010 versus 8.18% in 2011-2014) and MDR K. pneumoniae (2.38% in 2007-2010 versus 9.35% in 2011-2014) was evident and maintained constant over time in hospitalized patients in comparison to non-hospitalized ones. Infection due to MDR ESBL-producing E. coli and K. pneumoniae increased significantly during the last 8 years in both, hospitalized (20% versus 38% and 66.8% versus 82.6%, respectively) and non-hospitalized patients (18.2% versus 23.6% and 51% versus 74.6%, respectively).
CONCLUSIONS: This study includes data of a large sample size of urinary strains isolated over a 12 year period and demonstrates that MDR is an increasing phenomenon of particular importance in the main UTI-causing species.
Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Escherichia coli; Klebsiella pneumoniae; Multidrug resistance; Multirresistencia a antibióticos; Uropathogens; Uropatógenos

Mesh:

Substances:

Year:  2016        PMID: 27056582     DOI: 10.1016/j.eimc.2016.02.018

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  12 in total

1.  Genotypic to Phenotypic Resistance Discrepancies Identified Involving β-Lactamase Genes, blaKPC, blaIMP, blaNDM-1, and blaVIM in Uropathogenic Klebsiella pneumoniae.

Authors:  Umme Laila Urmi; Shamsun Nahar; Masud Rana; Fahmida Sultana; Nusrat Jahan; Billal Hossain; Mohammed Shah Alam; Abu Syed Md Mosaddek; Judy McKimm; Nor Azlina A Rahman; Salequl Islam; Mainul Haque
Journal:  Infect Drug Resist       Date:  2020-08-18       Impact factor: 4.003

2.  Nitroxoline: an option for the treatment of urinary tract infection with multi-resistant uropathogenic bacteria.

Authors:  Herbert Hof; C Juretschke
Journal:  Infection       Date:  2018-11-17       Impact factor: 3.553

3.  Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.

Authors:  A Dalhoff; S Schubert; A Vente
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 4.  Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance.

Authors:  Dong Sup Lee; Seung-Ju Lee; Hyun-Sop Choe
Journal:  Biomed Res Int       Date:  2018-09-26       Impact factor: 3.411

Review 5.  Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: A Systematic Review.

Authors:  Stéphanie Larramendy; Valentine Deglaire; Paul Dusollier; Jean-Pascal Fournier; Jocelyne Caillon; François Beaudeau; Leïla Moret
Journal:  Infect Drug Resist       Date:  2020-11-03       Impact factor: 4.003

6.  Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study.

Authors:  Ulrich Dobrindt; Haleluya T Wami; Torsten Schmidt-Wieland; Daniela Bertsch; Klaus Oberdorfer; Herbert Hof
Journal:  Antibiotics (Basel)       Date:  2021-05-28

7.  Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS).

Authors:  Marion Opatowski; Christian Brun-Buisson; Mehdi Touat; Jérôme Salomon; Didier Guillemot; Philippe Tuppin; Laurence Watier
Journal:  BMC Infect Dis       Date:  2021-06-14       Impact factor: 3.090

8.  Exploring the Genome and Phenotype of Multi-Drug Resistant Klebsiella pneumoniae of Clinical Origin.

Authors:  João Anes; Daniel Hurley; Marta Martins; Séamus Fanning
Journal:  Front Microbiol       Date:  2017-10-23       Impact factor: 5.640

9.  Urine Culture in Hospitalized Patients during 2014-2018: An Analysis on Pathogen Distribution and Drug Sensitivity.

Authors:  Dongkai Sun; Peishan Cong; Fengju Guan; Shuai Liu; Lijiang Sun; Guiming Zhang
Journal:  Dis Markers       Date:  2021-09-15       Impact factor: 3.434

10.  High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study.

Authors:  Peiyao Jia; Ying Zhu; Xue Li; Timothy Kudinha; Yang Yang; Ge Zhang; Jingjia Zhang; Yingchun Xu; Qiwen Yang
Journal:  Front Microbiol       Date:  2021-07-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.